MS Speaks
Multiple Sclerosis => TREATMENTS => OCREVUS (ocrelizumab) => Topic started by: agate on June 01, 2020, 09:12:14 pm
-
The infusion time for Ocrevus has been almost cut in half in Europe, and maybe the FDA will approve this shorter infusion time for MS patients in the US as well. From Multiple Sclerosis News Today (June 1, 2020):
https://multiplesclerosisnewstoday.com/news-posts/2020/06/01/ema-approves-two-hour-ocrevus-infusion-for-ms-patients-europe/